1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Working with Inside Sales

Discussion in 'Tricks of the Trade' started by Anonymous, Aug 31, 2013 at 3:03 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What has been your experience in working with inside sales? I manage inside sales teams for a number of large healthcare clients, and want to better understand from a field rep perspective what works well and what needs refinement. Managers tend to coat with fluff, but I know I'll get the real story from the field reps. Thanks!